Tuberculosis

•         Tb drug trials and pharmacokinetic studies
•         Concurrent treatment in TB and HIV co-infection
•         Treatment regimens for shortening Tb treatment
•          Pharmacokinetic profiles of anti-Tb drugs in Diabetic patients with Tb
•         Tb vaccine trials capacity development
•          Evaluation of surrogate markers for MTb drug resistance
•         Optimization of Tb diagnosis
•          Clinical features of Tb in HIV/AIDS

   Malaria

•        Malaria vaccine trials capacity building
•       Malaria drug clinical trials: assessment of efficacy, safety and pharmacokinetic profile of new anti-malaria drugs
•        Trials on mass drug administration in malaria endemic setting
•        Antimalarial drug clinical trials
•        Multi-drug resistance in malaria under combination therapy

  HIV

•    Prevention of rapid onset of Nevirapine resistance in PMTCT by Carbamazepine
•    Prevention of rapid onset of Nevirapine resistance in PMTCT by Phenytoin